Navigation Links
Replidyne to Report 2007 Fourth Quarter and Year-End Earnings
Date:2/5/2008

Presenting at BIO CEO & Investor Conference

LOUISVILLE, Colo., Feb. 5 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN) announced today that it will host a conference call on Tuesday, February 26, 2008 at 4:45 P.M. ET to report 2007 fourth quarter and year-end earnings. Additionally, Replidyne will present at an upcoming investor conference in February 2008.

Earnings conference call information is as follows:

Kenneth J. Collins, President and CEO, and other members of Replidyne's

senior management team will provide a company update and discuss

earnings results via conference call and webcast on Tuesday, February 26,

2008, at 4:45 P.M. ET. Callers may participate in the conference call by

dialing 866-510-0707 (domestic) or 617-597-5376 (international), and

providing the passcode 33794809. To access the live webcast, please log

on to the company's website at http://www.Replidyne.com and go to the

Investor Relations section.

A replay of the conference call will be available approximately one hour

after completion of the call through Tuesday, March 11, 2008 at midnight.

Callers may access the replay by dialing 888-286-8010 (U.S.

participants) or 617-801-6888 (international participants). The audio

replay passcode is 92464480. To access a replay of the webcast, visit

the Investor Relations section of the company's website at

http://www.Replidyne.com.

Investor conference presentation information is as follows:

-- Mr. Collins will present on Tuesday, February 12, 2008
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Replidyne to Announce Third Quarter 2007 Earnings
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, Inc. ... on gynecologic disease, announced today that investors including ... Birchview Fund LLC and several Vermillion directors have ... shares of Vermillion,s common stock and warrants to ... a private placement.  Under the ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations dedicated ... has further expanded its global reach with the affiliation ... Australia, reports Mylinda Vick, CCIM, Chairman of the ITRA ... ACORPP (Australian Corporate Property and Projects) , is a ... to a wide range of clients in the private ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... , , SINGAPORE, Sept. 14 ... that it has launched its website which is focused on ... agricultural biotech technologies. The website is located at www.chinaagrotech.com. ... Ltd. , China Agro-Technology Holdings Ltd., headquartered in Singapore, ...
... , , SAN ... discovering and developing a new class of naturally occurring proteins ... in San Francisco, CA on Friday, September 18th. Jeff ... aTyr Pharma,s technology, product engine, and lead program based on ...
... 14 CryoLife, Inc. (NYSE: CRY ) ... company, announced today that it is scheduled to participate in the ... York in New York City. , , Steven ... present Monday, September 21 at 2:00 p.m., Eastern Time. , ...
Cached Biology Technology:aTyr Pharma to Present at BioPharm America 2009 2CryoLife to Present at UBS Global Life Sciences Conference 2
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... at managing environmental impacts of agriculture have spurred ... and natural fertilizers for commercial applications. Many organic ... other processing industries. In Mississippi, where the poultry ... each year, and annual chicken litter production is ...
... warming, habitat loss, and other human impacts. But what ... ecosystems that humans depend on for goods and services? ... functions with fewer species in them? After decades of ... scientists any closer to attaining these answers? In a ...
... with impunity. Thousands of species that lacked culinary appreciation have ... on advanced DNA analysis has shown that this shameful indifference ... animal species came along that would learn to appreciate this ... Thus was born the human affection for the morel ...
Cached Biology News:Chicken litter provides organic alternative to synthetic fertilizers 2Will loss of plant diversity compromise Earth's life-support systems? 2Will loss of plant diversity compromise Earth's life-support systems? 3Will loss of plant diversity compromise Earth's life-support systems? 4Will loss of plant diversity compromise Earth's life-support systems? 5Genetic analysis reveals history, evolution of an ancient delicacy -- morels 2Genetic analysis reveals history, evolution of an ancient delicacy -- morels 3
... ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: NADP ... of HK will phosphorylate 1 ... min at 25C at pH ... will oxidize 1 mol of ...
... containing an overproducing clone of T4 DNA Ligase. ... a phosphodiester bond between juxtaposed 5' phosphoryl ... It repairs single-stranded nicks in duplex DNA, RNA ... and cohesive-end fragments of duplex DNA or RNA ...
... Kinase. This product is expected ... other mammalian species but has not ... a single precipitin line against partially ... shown to react with all forms ...
... of the COP9 signalosome complex (CSN), a ... processes. The CSN complex is an essential ... by mediating the deneddylation of the cullin ... complex is also involved in phosphorylation of ...
Biology Products: